Copper

Advances in Nutrition

Volumn 2, Issue 6, 2011, Pages 520-522

  Collins, James F ^a   Klevay, Leslie M ^b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; GLUCONIC ACID;

ADOLESCENT; ADULT; ANIMAL; CHILD; FEMALE; FOOD; HEALTH CARE POLICY; HUMAN; INFANT; IRON INTAKE; MALE; METABOLISM; MIDDLE AGED; NEWBORN; PREGNANCY; PRESCHOOL CHILD; REVIEW;

ADOLESCENT; ADULT; ANIMALS; CHILD; CHILD, PRESCHOOL; COPPER; FEMALE; FOOD; GLUCONATES; HUMANS; INFANT; INFANT, NEWBORN; IRON, DIETARY; MALE; MIDDLE AGED; NUTRITION POLICY; PREGNANCY; YOUNG ADULT;

EID: 84862275347     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.111.001222     Document Type: Note

References (20)

1. Klevay LM. Copper. In: Coates PM, Betz JM, Blackman MR, Cragg GM, Levine M, Moss J, White JD, et al, editors. Encyclopedia of dietary supplements. 2nd ed. London: Informa Healthcare; 2010. p. 175-84.
2. Reiser S, Smith JC Jr, Mertz W, Holbrook JT, Schofield DJ, Powell AS, Canfield WK, Canary JJ, et al. Indices of copper status in humans consuming a typical American diet containing either fructose or starch. Am J Clin Nutr. 1985; 42: 242-51.
3. Copper IOM. In: Dietary reference intakes for vitamin A vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: The National Academies Press; 2001. p. 224-57.
4. Kumar N. Copper deficiency myelopathy (human swayback). Mayo Clin Proc. 2006; 81: 1371-84.
5. Kelkar P, Chang S, Muley SA. Response to oral supplementation in copper deficiency myeloneuropathy. J Clin Neuromuscul Dis. 2008; 10: 1-3.
6. Prodan CI, Rabadi M, Vincent AS, Cowan LD. Copper supplementation improves functional activities of daily living in adults with copper deficiency. J Clin Neuromuscul Dis. 2011; 12: 122-8.
7. Pratt WB, Omdahl JL, Sorenson JR. Lack of effects of copper gluconate supplementation. Am J Clin Nutr. 1985; 42: 681-2.
8. Harvey LJ, McArdle HJ. Biomarkers of copper status: a brief update. Br J Nutr. 2008;99 SUPPL 3:S10-3
9. de Romaña DL, Olivares M, Uauy R, Araya M. Risks and benefits of copper in light of new insights of copper homeostasis. J Trace Elem Med Biol. 2011; 25: 3-13.
10. Fairweather-Tait SJ, Harvey LJ, Collings R. Risk-benefit analysis of mineral intakes: case studies on copper and iron. Proc Nutr Soc. 2011; 70: 1-9.
11. Jaiser SR, Winston GP. Copper deficiency myelopathy. J Neurol. 2010; 257: 869-81.
12. Martin JL. Inhaled anesthesia: metabolism and toxicity. In: Miller RD, Eriksson LI, Fleisher LA, Wiener-Kronish JP, Young WL, editors. Miller's anesthesia. 7th ed. Philadelphia: Churchill Livingstone; 2009. p. 633-66.
13. Online Mendelian Inheritance in Man. Johns Hopkins University. Mendelian inheritance in man [cited August 25, 2011]. Available from: http://omim.org/entry/156570.
14. Tamura T, Hong KH, Mizuno Y, Johnston KE, Keen CL. Folate and homocysteine metabolism in copper-deficient rats. Biochim Biophys Acta. 1999; 1427: 351-6.
15. Collins JF, Prohaska JR, Knutson MD. Metabolic crossroads of iron and copper. Nutr Rev. 2010; 68: 133-47.
16. Fox PL. The copper-iron chronicles: the story of an intimate relationship. Biometals. 2003; 16: 9-40.
17. Venakteshwara Rao M, Khanijo SK, Chande RD, Chouhan SS, Bisarya BN. Serum ceruloplasmin in iron deficiency anaemia. J Assoc Physicians India. 1975; 23: 571-6.
18. Ranganathan P, Lu Y, Jiang L, Kim C, Collins JF. Serum ceruloplasmin protein expression and activity increases in iron deficient rats and is further enhanced by higher dietary copper intake. Blood. Epub 2011 Jul 18.
19. Collins JF, Franck CA, Kowdley KV, Ghishan FK. Identification of differentially expressed genes in response to dietary iron deprivation in rat duodenum. Am J Physiol Gastrointest Liver Physiol. 2005;288:G964-71.
20. Ravia JJ, Stephen RM, Ghishan FK, Collins JF. Menkes copper ATPase (Atp7a) is a novel metal-responsive gene in rat duodenum, and immunoreactive protein is present on brush-border and basolateral membrane domains. J Biol Chem. 2005; 280: 36221-7.